Preliminary results from a Scripps Research and eMed digital medicine study show an unexpectedly high proportion of COVID-19 rebound cases in untreated people, as well as those treated with Paxlovid. “COVID rebound,” in which evidence of the illness disappears and then returns days or weeks later
A study by Scripps Research and eMed digital medicine shows a surprisingly high percentage of COVID-19 rebound cases in both untreated individuals and those treated with Paxlovid.
“These preliminary results suggest that rebound after clearance of SARS-CoV-2 test positivity or COVID-19 symptom resolution is more common than previously reported in both treated and untreated patients,” says study lead author Jay Pandit, MD, an assistant professor and director of Digital Medicine at the Scripps Research Translational Institute. “We’re going to need a larger set of participants and more extended follow-up to better understand this rebound phenomenon.
To help illuminate the rebound phenomenon and any connection to Paxlovid, Pandit and his colleagues teamed up with eMed to drive a “real-world” study of outcomes among people using the company’s COVID-19 Test-to-Treat antigen test kits with telehealth proctoring and telemedicine. Either way rebounds were measured, the Paxlovid group experienced them at a higher rate: 14.2% vs. 9.3% for antigen test rebounds, and 18.9% vs. 7.0% for symptom rebounds. With the small participant numbers included in this preliminary analysis, these differences were not statistically significant. Moreover, on other measures , the two groups had essentially identical outcomes. Age, gender and pre-existing conditions also did not appear to influence rebound.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A common and treatable cause of heart attacks is being overlookedTackling high cholesterol is one of the main ways doctors try to prevent heart attacks, but a growing number of researchers say we need to look at another key contributor: inflammation
Read more »
People Are Sharing Common Customs Or Habits Abroad That They Want The US To Adopt Immediately'It's embarrassing that it exists abroad — yet is not provided for free to all students.'
Read more »
Housing rebound: Top real estate economist sees home prices risingA top real estate economist explains why a housing rebound is coming as rising sales and lack of supply look poised to lift home prices
Read more »
3 common banking scams and how to avoid themAbout 2.8 million U.S. consumers reported more than $5.8 billion in losses to fraud in 2021 — up 70% compared with 2020, Federal Trade Commission data shows.
Read more »
Watch these 5 cryptocurrencies for a potential price rebound next weekAltcoins such as ETH, MATIC, TON, and OKB which are above their 200-day SMA could start a recovery if Bitcoin sustains above $20,000 in the near term.
Read more »
Medical tourism: Traveling outside US for care is commonTraveling outside of the U.S. for medical care is common primarily due to lower costs, and easier access.
Read more »